Jan De Witte - Nov 1, 2023 Form 4 Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Role
President & CEO, Director
Signature
/s/ Eric Schwartz; Attorney-in-Fact
Stock symbol
IART
Transactions as of
Nov 1, 2023
Transactions value $
-$157,055
Form type
4
Date filed
11/3/2023, 04:27 PM
Previous filing
Jun 2, 2023
Next filing
Nov 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IART Common Stock Options Exercise $0 +9.81K +76.68% $0.00 22.6K Nov 1, 2023 Direct F1
transaction IART Common Stock Tax liability -$157K -4.26K -18.85% $36.85 18.4K Nov 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IART Restricted Stock Units Options Exercise $0 -9.81K -9.83% $0.00 90K Nov 1, 2023 Common Stock 9.81K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 1, 2022, the reporting person was granted a restricted stock unit award which vests in three equal annual installments on the first, second and third anniversaries of the grant date of 11/01/2022 and which convert into shares of common stock on a one-for-one basis. The first installment vested on 11/1/2023.